Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Chargement...
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
Peganum harmala var.
Calculateur gratuit de posologie — doses adultes et enfants selon le poids.
Peganum harmala contains beta-carboline alkaloids, primarily harmine and harmaline, which act as reversible monoamine oxidase inhibitors (MAOIs). These compounds inhibit MAO-A and MAO-B enzymes, preventing the breakdown of neurotransmitters like serotonin, dopamine, and norepinephrine. This mechanism explains both its traditional use for mental conditions and its significant drug interaction potential. Evidence level C supports these pharmacological actions based on in vitro and animal studies.
Harmal seeds pose serious drug interaction risks due to their MAO-inhibiting properties. Combining harmal with antidepressants (SSRIs, SNRIs, tricyclics), tyramine-containing foods, or other MAOIs can trigger serotonin syndrome or hypertensive crisis. Additional interactions occur with central nervous system depressants, stimulants, and certain blood pressure medications. These interactions can be life-threatening. Evidence level C confirms these risks. Professional medical guidance is essential before any use, and self-medication is strongly discouraged.
Traditional use of Peganum harmala involves extremely small quantities, typically as fumigant incense rather than internal consumption. No standardized therapeutic dosage exists due to the narrow therapeutic window and toxicity concerns. The seeds contain potent alkaloids that can cause serious adverse effects even at low doses. Evidence level C indicates insufficient clinical data to establish safe dosing parameters. Self-medication is contraindicated, and any use should occur only under qualified professional supervision.
Harmal is contraindicated during pregnancy and breastfeeding. The uterine stimulant properties of harmal seeds can induce uterine contractions, potentially causing miscarriage or premature labor. Alkaloids including harmine and harmaline may pass into breast milk, posing risks to nursing infants. Traditional use as an emmenagogue further confirms its uterine effects. Evidence level C supports these safety concerns. Women who are pregnant, nursing, or attempting to conceive should avoid all forms of Peganum harmala completely.
Persian traditional medicine uses harmal seeds primarily as a fumigant against evil eye and for mental conditions. Moroccan and Central Asian traditions similarly employ the seeds as incense and occasionally as an anthelmintic against parasites. Traditional applications also include use as a uterine stimulant. Evidence level C indicates limited clinical validation for these traditional uses. The plant's MAO-inhibiting alkaloids explain some reported psychoactive effects, though these same properties create significant safety concerns.
Cette plante ne dispose pas d'une monographie rédigée par un humain, et le contenu généré par IA n'est pas affiché ici. Consultez les sources gouvernementales et les études primaires PubMed (NIH) listées ci-dessous pour des informations fiables. Confirmez toujours auprès d'un professionnel de santé avant utilisation.
Aucune monographie gouvernementale directe n'est disponible pour cette plante. Le contenu ci-dessous est généré par IA et n'a pas été vérifié par rapport à une source gouvernementale faisant autorité. Utilisez les liens de recherche pour consulter les sources officielles avant de vous fier à ces informations.